Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen

NCT03934450 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Malaria
Glucose 6 Phosphate Dehydrogenase Deficiency

Interventions

DRUG: RPQ
DRUG: SPQ
DRUG: Primaquine Phosphate
DRUG: Placebo

Sponsor

University of Mississippi, Oxford